SPECIAL NOTICE
A -- Office of Biomedical Advanced Research and Development Authority Broad Agency Announcement (BAA)
- Notice Date
- 11/21/2023 11:18:09 AM
- Notice Type
- Special Notice
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- ASPR OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE Washington DC 20201 USA
- ZIP Code
- 20201
- Response Due
- 9/29/2023 1:29:00 PM
- Archive Date
- 10/14/2023
- Point of Contact
- Deitra Williams, Corneilus Stephens
- E-Mail Address
-
Deitra.Williams@hhs.gov, Corneilus.Stephens@hhs.gov
(Deitra.Williams@hhs.gov, Corneilus.Stephens@hhs.gov)
- Description
- The overall objective of this contract is that the Contractor will function as the USG�s�centralized assay laboratory for immune assay development and high throughput�testing for sera and mucosal samples for primary, secondary, exploratory endpoints and/or post-hoc analyses for vaccine clinical studies. Specifically, the data gathered�from the clinical study samples testing will be used in primary, secondary,�exploratory endpoint and/or post-hoc analyses for vaccine clinical studies. Data may�be used to support U.S. FDA EUA or BLA, or other regulatory agency submissions,�as well as monitoring their subsequent efficacy against newly emerging variant�viruses. The scope of work includes providing development and testing services to the USG for�immune assays. These immune assays shall include development of qualified (and if�needed) validated pseudotyped virus neutralization (PsVN), IgG and IgA binding MSDECL�assays, ACE2-receptor blocking assays for sera and mucosal samples. Additionally,�PPD will perform high throughput testing of human serum and mucosal samples using the�above-mentioned assays in compliance with Good Clinical Laboratory Practices (GCLP). The Contractor's success in completing the required tasks under the work segments must�be demonstrated through the Deliverables and Milestones specified under Article F of this�contract.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/6df3f908fc774f819ae1116ce754fc2d/view)
- Place of Performance
- Address: Richmond, VA, USA
- Country: USA
- Country: USA
- Record
- SN06891224-F 20231123/231121230045 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |